Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACHV | IKT | CRDL | ||
| Company | Achieve Life Sciences Inc | Inhibikase Therapeutics Inc | Cardiol Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.30 | 2.02 | 1.6500 | ||
| High | 4.34 | 2.39 | 1.6550 | ||
| Low | 4.21 | 1.96 | 1.5579 | ||
| Last | 4.29 | 2.31 | 1.6200 | ||
| Change | -0.04 | +0.30 | +0.0400 | ||
| % Change | -0.92% | +14.93% | +2.53% | ||
| Volume | 94,300 | 199,300 | 405,400 | ||
| 20-Day Average Volume | 120,655 | 310,900 | 429,895 | ||
| Previous Close | 4.33 | 2.01 | 1.5800 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.59 | 2.49 | 1.8340 | ||
| 20-Day Raw Stochastic | 14.29% | 28.87% | 17.33% | ||
| 20-Day Relative Strength | 41.61% | 53.84% | 37.72% | ||
| Weighted Alpha | +2.49 | +35.30 | +21.93 | ||
| Today's Opinion | 72% Sell | 64% Buy | 88% Sell | ||
| Previous Opinion | 72% Sell | 64% Buy | 88% Sell | ||
| Last Month's Opinion | 8% Buy | 32% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.94% since 11/15/24 | +12.68% since 11/15/24 | -10.99% since 11/15/24 | ||
| Low | 4.12 on 11/18/24 | 1.75 on 11/21/24 | 1.4900 on 11/21/24 | ||
| High | 4.46 on 11/19/24 | 2.39 on 11/22/24 | 1.9200 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | -12.27% since 10/22/24 | +9.48% since 10/22/24 | -13.37% since 10/22/24 | ||
| Low | 4.12 on 11/18/24 | 1.75 on 11/21/24 | 1.4900 on 11/21/24 | ||
| High | 5.31 on 11/06/24 | 3.69 on 11/08/24 | 2.2400 on 11/07/24 | ||
| 3-Month | |||||
| %Chg | -2.61% since 08/22/24 | +68.61% since 08/22/24 | -20.20% since 08/22/24 | ||
| Low | 4.10 on 09/06/24 | 1.12 on 09/25/24 | 1.4900 on 11/21/24 | ||
| High | 5.31 on 11/06/24 | 3.69 on 11/08/24 | 2.6300 on 09/13/24 | ||
| 6-Month | |||||
| %Chg | -16.70% since 05/22/24 | +22.22% since 05/22/24 | -25.69% since 05/22/24 | ||
| Low | 4.10 on 09/06/24 | 1.12 on 09/25/24 | 1.4900 on 11/21/24 | ||
| High | 5.59 on 05/29/24 | 3.69 on 11/08/24 | 3.1200 on 06/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 147,533 | 155,216 | 132,197 | ||
| Shares Outstanding, K | 34,390 | 67,193 | 81,603 | ||
| Annual Sales | 0 | 260,000 | 0 | ||
| Annual Net Income | -29,820,000 | -19,030,000 | -20,840,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -12,510,000 | -5,780,000 | -9,330,000 | ||
| 60-Month Beta | 1.57 | 1.11 | 0.91 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.36 on 11/07/24 | -0.65 on 11/14/24 | -0.13 on 11/14/24 | ||
| Latest Earnings Date | 11/07/24 | 11/12/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||